Chemical Compound

cis-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone; Atovaquone Related Compound A (USP); Atovaquone Imp. B (EP); 296C85; USP Atovaquone Related Compound A; GR 261266X

CAS Registry Number 95233-18-4
返回搜索 申请报价
cis-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone; Atovaquone Related Compound A (USP); Atovaquone Imp. B (EP); 296C85; USP Atovaquone Related Compound A; GR 261266X 结构式
Primary record

cis-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone; Atovaquone Related Compound A (USP); Atovaquone Imp. B (EP); 296C85; USP Atovaquone Related Compound A; GR 261266X

库存
3,852 克
纯度
98.9 %
CAS
95233-18-4

化合物标识与属性

CAS
95233-18-4
PubChem CID
74989
SMILES
C1CC(CCC1C2=CC=C(C=C2)Cl)C3=C(C4=CC=CC=C4C(=O)C3=O)O
Canonical SMILES
O=C1C(=O)c2ccccc2C(O)=C1C1CCC(c2ccc(Cl)cc2)CC1

名称与同义词

  • ATOVAQUONE
  • Mepron
  • Wellvone
  • cis-Atovaquone
  • Acuvel
  • 95233-18-4
  • Atavaquone
  • Malarone
  • atovacuona
  • Malarone Pediatric
  • pron
  • Atovaquona
  • Mixture Name
  • Atovaquone CRS
  • Atovaquone-d5
  • Mepron (antipneumocystic)
  • Mepron;
  • Mepron (TN)
  • Compound 566
  • Atovaquone EP Impurity B
  • ATOVAQUONE-D4
  • Atovaquone (Atavaquone)
  • C22H19ClO3
  • 566C80
  • Malarone (Salt/Mix)
  • Atovaquone (Standard)
  • F1W7QUV0KI
  • Spectrum_001743
  • BW 566C
  • starbld0018905
  • ATOVAQUONE [MI]
  • SpecPlus_000686
  • Atovaquone (USP/INN)
  • Atovaquone [USAN:BAN:INN]
  • AC1L2MZG
  • ATOVAQUONE [INN]
  • ATOVAQUONE [JAN]
  • 137732-39-9
  • CRL-8131 & Atovaquone
  • Prestwick0_000534
  • Prestwick1_000534
  • Prestwick2_000534
  • Prestwick3_000534
  • Spectrum2_001665
  • Spectrum3_000991
  • Spectrum4_001117
  • Spectrum5_001382
  • UNII-F1W7QUV0KI
  • Atovaquone (Atavaquone)?
  • ATOVAQUONE [HSDB]
  • ATOVAQUONE [USAN]
  • UNII-Y883P1Z2LT
  • RefChem:1066764
  • Atovaquone & Interleukin 12
  • ATOVAQUONE [VANDF]
  • Atovaquone Related Compound A
  • CIS-ATOVAQUONE (RACEMIC)
  • D06ZEE
  • BW-A 566C
  • DRG-0084
  • HSDB 7083
  • AC1Q6E9K
  • ATOVAQUONE [MART.]
  • BW-566C
  • 566C
  • Y883P1Z2LT
  • ATOVAQUONE [USP-RS]
  • ATOVAQUONE [WHO-DD]
  • CHEMBL1450
  • SCHEMBL21694
  • SCHEMBL21695
  • Atovaquone (JAN/USP/INN)
  • BSPBio_000547
  • BSPBio_002681
  • DTXSID7022629
  • KBioGR_001594
  • KBioSS_002223
  • ATO & IL-12
  • MLS002153863
  • 566C80 hydroxynaphthoquinone
  • Atovaquone [USAN:INN:BAN]
  • BIDD:GT0849
  • BW 566C-80
  • DivK1c_006782
  • hydroxynaphthoquinone 566C80
  • SCHEMBL637069
  • SPECTRUM1504210
  • DTXSID20916694
  • SPBio_001849
  • SPBio_002468
  • KUCQYCKVKVOKAY-UHFFFAOYSA-N
  • 566C80, hydroxynaphthoquinone
  • 94015-53-9
  • Atovaquone - Bio-X trade mark
  • Atovaquone [USAN:USP:INN:BAN]
  • BPBio1_000603
  • CHEMBL222334
  • CHEMBL471792
  • CHEMBL519462
  • DTXCID602629
  • GTPL9695
  • hydroxynaphthoquinone, 566C80
  • NAP016
  • orb1308475
  • SCHEMBL1542719
  • SCHEMBL1649508
  • SCHEMBL9975142
  • atovaquone GlaxoSmithKline brand
  • ATOVAQUONE [ORANGE BOOK]
  • Atovaquone, >=98% (HPLC)
  • BW-566C-80
  • NSC-759582
  • SCHEMBL29559044
  • Atovaquone for system suitability
  • CHEBI:95346
  • CTK5H7581
  • KBio1_001726
  • KBio2_002223
  • KBio2_004791
  • KBio2_007359
  • KBio3_001901
  • ATOVAQUONE [EP MONOGRAPH]
  • C22-H19-Cl-O3
  • DTXCID20888847
  • BW 566C80
  • CHEBI:575568
  • KUCQYCKVKVOKAY-CTYIDZIISA-N
  • KUCQYCKVKVOKAY-OTVXOJSOSA-N
  • MFCD00889188
  • ATOVAQUONE [USP MONOGRAPH]
  • BDBM192009
  • Glaxo Wellcome brand of atovaquone
  • GLXC-02590
  • HMS1569L09
  • HMS1922F19
  • HMS2089M14
  • HMS2093C10
  • HMS2096L09
  • HMS2235N08
  • HMS3369N09
  • HMS3651N20
  • HMS3713L09
  • HMS5081E14
  • Pharmakon1600-01504210
  • GlaxoSmithKline brand of atovaquone
  • AMY15339
  • BCP09477
  • CID74989
  • KS-00000FO3
  • MALARONE COMPONENT ATOVAQUONE
  • MFA73239
  • VHD01514
  • 3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione
  • Tox21_110714
  • AR-1H7607
  • Atovaquone related compound A [USP]
  • CCG-39090
  • EBC-06068
  • EBC-67042
  • FD7252
  • HY-13832R
  • NCGC00016961-01
  • NSC759582
  • s3079
  • STK636160
  • ZINC12504271
  • Atovaquone for system suitability CRS
  • AKOS005567953
  • AKOS015895691
  • AKOS015961933
  • Atovaquone 100 microg/mL in Acetonitrile
  • Tox21_110714_1
  • ZINC100017856
  • ZINC100345537
  • ZINC116473771
  • ZINC299873031
  • 2-(trans-4-(p-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
  • AN-6439
  • BW 556C-80
  • BW-556C-80
  • CCG-220534
  • CS-2702
  • DB01117
  • FA18025
  • NSC 759582
  • CAS-95233-18-4
  • 2-(TRANS-4-(4-CHLOROPHENYL)CYCLOHEXYL)-3-HYDROXY-1,4-NAPHTHALENEDIONE
  • NCGC00016961-02
  • NCGC00016961-03
  • NCGC00016961-04
  • NCGC00016961-06
  • NCGC00016961-07
  • NCGC00016961-11
  • NCGC00095113-01
  • NCGC00095113-02
  • AC-30251
  • AK544285
  • AS-12809
  • BA164228
  • BC208879
  • HY-13832
  • SC-15688
  • SC-21393
  • SMR001233220
  • SBI-0052893.P002
  • 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone
  • AB0012456
  • AB0107187
  • AB0211463
  • J389.528I
  • LS-178256
  • TX-010638
  • A2545
  • AB00513855
  • B2078
  • FT-0602868
  • NS00010018
  • NS00077594
  • SW219222-1
  • J1.549.967B
  • MALARONE PEDIATRIC COMPONENT ATOVAQUONE
  • 2-(4-(4-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
  • 2-(4-(4-Chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-1,4-dione
  • A13708
  • ATOVAQUONE RELATED COMPOUND A [USP-RS]
  • C06835
  • cis-Atovaquone-d5 (contains 10% trans isomer)
  • D00236
  • EN300-120639
  • EN300-731648
  • F18448
  • J90007
  • SBI-0052893.0001
  • 78668-EP2307343A1
  • AB00053222-03
  • AB00053222_04
  • AB00053222_05
  • 2-((1r,4r)-4-(4-chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-1,4-dione
  • 2-[trans-4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione
  • 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione
  • 233A184
  • 566C-80
  • F390345
  • Q418179
  • SR-05000001438
  • 1-(1,3-Thiazol-2-yl)-1H-pyrrole-2-carbaldehyde
  • 3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxy-naphthalene-1,2-dione
  • ATOVAQUONE RELATED COMPOUND A [USP IMPURITY]
  • I06-0872
  • SR-05000001438-1
  • SR-05000001438-2
  • SR-05000001438-4
  • SR-05000001438-5
  • 2-(4-(4-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-nap
  • 2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-1,4-dione
  • trans-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione
  • 1,4-Naphthalenedione, 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-, trans-
  • 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-dihydronaphthalene-1,4-dione
  • 3-(4-(4-chlorophenyl)cyclohexyl)-4-hydroxynaphthalene-1,2-dione
  • Z2588038997
  • 2-(cis-4-(4-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthalenedione
  • 2-(cis-4-(4-Chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-1,4-dione
  • 2-[trans-4-(p-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone
  • cis-2-(4-(4-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
  • trans-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone
  • 1,4-Naphthalenedione, 2-(cis-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-
  • 1,4-Naphthalenedione, 2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-
  • 2-[4-(4-chlorophenyl)cyclohexy]-3-hydroxy-1,4-naphthoquinone
  • 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone
  • 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-napthoquinone
  • 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1.4-naphthoquinone
  • 2-Hydroxy-3-[4-(4-chlorophenyl)cyclohexyl]-1,4-naphthoquinone
  • 3-[4-(p-chlorophenyl)cyclohexyl]-4-hydroxy-1,2-naphthoquinone
  • 1,2-Naphthalenedione, 3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxy-
  • 1,4-Naphthalenedione, 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-
  • 2-(4-(4'-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
  • 2-[4-(4-chlorophenyl)-cyclohexyl]-3-hydroxy-1,4-naphthoquinone
  • 2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-naphthalene-1,4-dione
  • 2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxynaphthoquinone, trans-
  • 2-hydroxy-3-[(1r,4r)-4-(4-chlorophenyl)cyclohexyl]-1,4-dihydronaphthalene-1,4-dione
  • 3-(4-(4-chlorophenyl)cyclohexyl)-4-hydroxy-naphthalene-1,2-dione
  • 3-[4-(4-Chlorophenyl)cyclohexyl]-4-hydroxy-1,2-naphthalenedione
  • Cis-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone
  • 1,4-Naphthalenedione, 2-[cis-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-
  • 1,4-Naphthalenedione, 2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy
  • 1,4-naphthalenedione,2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-
  • 2-((1s,4s)-4-(4-chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-1,4-dione
  • 2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
  • 2-[(1r,4r)-4-(4-Chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione
  • cis -2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-1,4-dione
  • trans-2-(4-(4-chlorophenyl) cyclohexyl)-3-hydroxynaphthalene-1,4-dione
  • 2-[(1alpha)-4beta-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone
  • 3-Hydroxy-2-[4beta-(4-chlorophenyl)cyclohexan-1alpha-yl]naphthalene-1,4-dione
  • Atovaquone; 2-[trans-4-(4-Chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione; 566C80
  • 1217612-80-0
  • 1329792-63-3
  • 2070015-14-2
  • 630-425-2
  • 996-42-9
  • ATQ
  • cis-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione; USP Atovaquone Related Compound A; Atorvastatin EP Impurity B
  • cis-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone; Atovaquone Related Compound A (USP); Atovaquone Imp. B (EP); 296C85; USP Atovaquone Related Compound A; GR 261266X